On March 3, 2022, Jeff Goater informed Vaccinex, Inc. that due to new responsibilities and conflicting demands on his time, he will not stand for re-election as a director at the Company's 2022 annual meeting of stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.41 USD | -10.63% | +28.20% | -31.13% |
16/05 | Earnings Flash (VCNX) VACCINEX Reports Q1 Revenue $104,000 | MT |
12/04 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-31.13% | 10.16M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.63% | 22.67B | |
-9.81% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- VCNX Stock
- News Vaccinex, Inc.
- Jeff Goater Not to Stand for Re-Election as a Director of Vaccinex, Inc